https://www.selleckchem.com/pr....oducts/oxalacetic-ac
As treatments for rectal cancer improve with developments in surgical techniques, radiotherapy and chemotherapy, the nature of recurrences are evolving. We used a comprehensive database of a large Australian population with stage I-III rectal adenocarcinoma to identify timing and prognostic significance of recurrences, and factors associated with risk of developing recurrent disease. All patients with locoregional rectal cancer treated with curative intent in our health district from 2006 to 2017 were included. Multivariate anal
Like
Comment
Share
